Takeda, Sanford-Burnham Ink Obesity Discovery Deal To Explore Non-CNS Options

Takeda Pharmaceutical Co. Ltd. and the Sanford-Burnham Medical Research Institute have formed a collaboration focused on identifying and validating new targets and pathways outside of the central nervous system for treating obesity